Article Details

Truvian raises $105 million to commercialize its automated blood-testing platform

Retrieved on: 2021-02-24 12:01:36

Tags for this article:

Click the tags to see associated articles and topics

Truvian raises $105 million to commercialize its automated blood-testing platform. View article details on hiswai:

Excerpt

GreatPoint Ventures, General Catalyst, DNS Capital, and Wasson Enterprise also participated in Truvian's latest funding round. It brings the company's ...

Article found on: venturebeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo